Cargando…

Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer’s disease

A novel multifunctional series of 3-aminobenzofuran derivatives 5a-p were designed and synthesized as potent inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The target compounds 5a-p were prepared via a three-step reaction, starting from 2-hydroxy benzonitrile. In vitro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasanvand, Zaman, Motahari, Rasoul, Nadri, Hamid, Moghimi, Setareh, Foroumadi, Roham, Ayati, Adileh, Akbarzadeh, Tahmineh, Bukhari, Syed Nasir Abbas, Foroumadi, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395670/
https://www.ncbi.nlm.nih.gov/pubmed/36017161
http://dx.doi.org/10.3389/fchem.2022.882191
_version_ 1784771751405682688
author Hasanvand, Zaman
Motahari, Rasoul
Nadri, Hamid
Moghimi, Setareh
Foroumadi, Roham
Ayati, Adileh
Akbarzadeh, Tahmineh
Bukhari, Syed Nasir Abbas
Foroumadi, Alireza
author_facet Hasanvand, Zaman
Motahari, Rasoul
Nadri, Hamid
Moghimi, Setareh
Foroumadi, Roham
Ayati, Adileh
Akbarzadeh, Tahmineh
Bukhari, Syed Nasir Abbas
Foroumadi, Alireza
author_sort Hasanvand, Zaman
collection PubMed
description A novel multifunctional series of 3-aminobenzofuran derivatives 5a-p were designed and synthesized as potent inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The target compounds 5a-p were prepared via a three-step reaction, starting from 2-hydroxy benzonitrile. In vitro anti-cholinesterase activity exhibited that most of the compounds had potent acetyl- and butyrylcholinesterase inhibitory activity. In particular, compound 5f containing 2-fluorobenzyl moiety showed the best inhibitory activity. Furthermore, this compound showed activity on self- and AChE-induced Aβ-aggregation and MTT assay against PC12 cells. The kinetic study revealed that compound 5f showed mixed-type inhibition on AChE. Based on these results, compound 5f can be considered as a novel multifunctional structural unit against Alzheimer’s disease.
format Online
Article
Text
id pubmed-9395670
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93956702022-08-24 Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer’s disease Hasanvand, Zaman Motahari, Rasoul Nadri, Hamid Moghimi, Setareh Foroumadi, Roham Ayati, Adileh Akbarzadeh, Tahmineh Bukhari, Syed Nasir Abbas Foroumadi, Alireza Front Chem Chemistry A novel multifunctional series of 3-aminobenzofuran derivatives 5a-p were designed and synthesized as potent inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The target compounds 5a-p were prepared via a three-step reaction, starting from 2-hydroxy benzonitrile. In vitro anti-cholinesterase activity exhibited that most of the compounds had potent acetyl- and butyrylcholinesterase inhibitory activity. In particular, compound 5f containing 2-fluorobenzyl moiety showed the best inhibitory activity. Furthermore, this compound showed activity on self- and AChE-induced Aβ-aggregation and MTT assay against PC12 cells. The kinetic study revealed that compound 5f showed mixed-type inhibition on AChE. Based on these results, compound 5f can be considered as a novel multifunctional structural unit against Alzheimer’s disease. Frontiers Media S.A. 2022-08-09 /pmc/articles/PMC9395670/ /pubmed/36017161 http://dx.doi.org/10.3389/fchem.2022.882191 Text en Copyright © 2022 Hasanvand, Motahari, Nadri, Moghimi, Foroumadi, Ayati, Akbarzadeh, Bukhari and Foroumadi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Hasanvand, Zaman
Motahari, Rasoul
Nadri, Hamid
Moghimi, Setareh
Foroumadi, Roham
Ayati, Adileh
Akbarzadeh, Tahmineh
Bukhari, Syed Nasir Abbas
Foroumadi, Alireza
Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer’s disease
title Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer’s disease
title_full Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer’s disease
title_fullStr Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer’s disease
title_full_unstemmed Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer’s disease
title_short Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer’s disease
title_sort novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of alzheimer’s disease
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395670/
https://www.ncbi.nlm.nih.gov/pubmed/36017161
http://dx.doi.org/10.3389/fchem.2022.882191
work_keys_str_mv AT hasanvandzaman novel3aminobenzofuranderivativesasmultifunctionalagentsforthetreatmentofalzheimersdisease
AT motaharirasoul novel3aminobenzofuranderivativesasmultifunctionalagentsforthetreatmentofalzheimersdisease
AT nadrihamid novel3aminobenzofuranderivativesasmultifunctionalagentsforthetreatmentofalzheimersdisease
AT moghimisetareh novel3aminobenzofuranderivativesasmultifunctionalagentsforthetreatmentofalzheimersdisease
AT foroumadiroham novel3aminobenzofuranderivativesasmultifunctionalagentsforthetreatmentofalzheimersdisease
AT ayatiadileh novel3aminobenzofuranderivativesasmultifunctionalagentsforthetreatmentofalzheimersdisease
AT akbarzadehtahmineh novel3aminobenzofuranderivativesasmultifunctionalagentsforthetreatmentofalzheimersdisease
AT bukharisyednasirabbas novel3aminobenzofuranderivativesasmultifunctionalagentsforthetreatmentofalzheimersdisease
AT foroumadialireza novel3aminobenzofuranderivativesasmultifunctionalagentsforthetreatmentofalzheimersdisease